Importer of Controlled Substances; Notice of Registration; Cambrex Charles City, Inc., 55503-55504 [2012-22157]
Download as PDF
<![CDATA[
55503
Federal Register / Vol. 77, No. 175 / Monday, September 10, 2012 / Notices
Aggregate production quotas for all
other Schedule I and II controlled
substances included in 21 CFR 1308.11
and 1308.12 remain at zero.
Dated: August 31, 2012.
Michele M. Leonhart,
Administrator.
[FR Doc. 2012–22128 Filed 9–7–12; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA 353]
Final Adjusted Assessment of Annual
Needs for the List I Chemicals
Ephedrine, Pseudoephedrine, and
Phenylpropanolamine for 2012
Drug Enforcement
Administration (DEA), Department of
Justice.
ACTION: Notice.
AGENCY:
This notice establishes the
Final Adjusted 2012 Assessment of
Annual Needs for the list I chemicals
ephedrine, pseudoephedrine, and
phenylpropanolamine.
SUMMARY:
DATES:
Effective Date: September 10,
2012.
John
W. Partridge, Chief, Liaison and Policy
Section, Drug Enforcement
Administration, 8701 Morrissette Drive,
Springfield, VA 22152, Telephone: (202)
307–4654.
SUPPLEMENTARY INFORMATION: The 2012
Assessment of Annual Needs represents
those quantities of ephedrine,
pseudoephedrine, and
phenylpropanolamine which may be
manufactured domestically and
imported into the United States in 2012
to provide adequate supplies of each
chemical for the estimated medical,
scientific, research, and industrial needs
of the United States, lawful export
requirements, and the establishment
and maintenance of reserve stocks of
such chemicals. Section 306 of the
Controlled Substances Act (CSA) (21
U.S.C. 826) requires that the Attorney
General establish an assessment of
annual needs for ephedrine,
pseudoephedrine, and
phenylpropanolamine. This
responsibility has been delegated to the
Administrator of the DEA by 28 CFR
0.100.
On July 18, 2012, a notice entitled
‘‘Proposed Adjustment of the
Assessment of Annual Needs for the List
I Chemicals Ephedrine,
Pseudoephedrine, and
mstockstill on DSK4VPTVN1PROD with NOTICES
FOR FURTHER INFORMATION CONTACT:
VerDate Mar<15>2010
16:57 Sep 07, 2012
Jkt 226001
Phenylpropanolamine for 2012’’ was
published in the Federal Register (77
FR 42333). That notice proposed to
adjust the 2012 Assessment of Annual
Needs for ephedrine (for sale),
ephedrine (for conversion),
pseudoephedrine (for sale),
phenylpropanolamine (for sale) and
phenylpropanolamine (for conversion).
All interested persons were invited to
comment on or object to the proposed
assessments on or before August 17,
2012.
Comments Received
DEA did not receive any comments to
the proposed adjustment of the
assessment of annual needs for
ephedrine (for sale), ephedrine (for
conversion), pseudoephedrine (for sale),
phenylpropanolamine (for sale), and
phenylpropanolamine (for conversion).
Conclusion
In determining the adjusted 2012
assessments, DEA used the calculation
methodology previously described in
the 2010 and 2011 assessment of annual
needs (74 FR 60294 and 75 FR 79407
respectively). DEA considered changes
in demand, changes in the national rate
of net disposal, and changes in the rate
of net disposal by the registrants
holding individual manufacturing or
import quotas for the chemical; whether
any increased demand or changes in the
national and/or individual rates of net
disposal are temporary, short term, or
long term; whether any increased
demand could be met through existing
inventories, increased individual
manufacturing quotas, or increased
importation without increasing the
assessment of annual needs; whether
any decreased demand would result in
excessive inventory accumulation by all
persons registered to handle the
particular chemical; and other factors
affecting the medical, scientific,
research, industrial, and importation
needs in the United States, lawful
export requirements, and reserve stocks,
as found relevant.
Other factors that DEA considered
include trends as derived from
information provided in applications for
import, manufacturing, and
procurement quotas and in import and
export declarations. The inventory,
acquisition (purchases), and disposition
(sales) data as provided by DEAregistered manufacturers and importers
reflects the most current information
available to DEA at the time of
publication of this Notice. The
underlying data used to determine the
final 2012 assessment of annual needs is
the same as that used in determining the
proposed 2012 assessment of annual
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
needs, as published on September 14,
2011, at 76 FR 56809.
In accordance with 21 U.S.C. 826(a)
and 21 CFR 1315.13, the Administrator
hereby orders that the 2012 assessment
of annual needs for ephedrine,
pseudoephedrine, and
phenylpropanolamine, expressed in
kilograms of anhydrous acid or base, is
adjusted and established as follows:
List I chemical
Final 2012
assessment of
annual needs
(kg)
Ephedrine (for sale) ..............
Phenylpropanolamine (for
sale) ..................................
Pseudoephedrine (for sale) ..
Phenylpropanolamine (for
conversion) ........................
Ephedrine (for conversion) ...
4,300
5,800
278,000
26,200
12,000
Dated: August 31, 2012.
Michele M. Leonhart,
Administrator.
[FR Doc. 2012–22127 Filed 9–7–12; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration; Cambrex
Charles City, Inc.
By Notice dated June 18, 2012, and
published in the Federal Register on
June 26, 2012, 77 FR 38085, Cambrex
Charles City, Inc., 1205 11th Street,
Charles City, Iowa 50616–3466, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as an importer of the
following basic classes of controlled
substances:
Drug
4-Anilino-N-phenethyl-4-piperidine
(8333).
Phenylacetone (8501) ..................
Opium, raw (9600) .......................
Poppy Straw Concentrate (9670)
Schedule
II
II
II
II
The company plans to import the
listed controlled substances for internal
use, and to manufacture bulk
intermediates for sale to its customers.
No comments or objections have been
received. Comments and requests for
hearings on applications to import
narcotic raw material are not
appropriate. 72 FR 3417 (2007).
DEA has considered the factors in 21
U.S.C. 823(a) and 952(a), and
determined that the registration of
Cambrex Charles City, Inc. to import the
E:\FR\FM\10SEN1.SGM
10SEN1
55504
Federal Register / Vol. 77, No. 175 / Monday, September 10, 2012 / Notices
basic classes of controlled substances is
consistent with the public interest, and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971. DEA
has investigated Cambrex Charles City,
Inc. to ensure that the company’s
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
physical security systems, verification
of the company’s compliance with state
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C
.952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the above named
company is granted registration as an
importer of the basic classes of
controlled substances listed.
Dated: August 29, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
physical security systems, verification
of the company’s compliance with state
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: August 29, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2012–22154 Filed 9–7–12; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
[FR Doc. 2012–22157 Filed 9–7–12; 8:45 am]
Drug Enforcement Administration
BILLING CODE 4410–09–P
Manufacturer of Controlled
Substances, Notice of Registration,
Noramco, Inc., (GA)
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration;
Research Triangle Institute
By Notice dated May 15, 2012, and
published in the Federal Register on
May 22, 2012, 77 FR 30327, Research
Triangle Institute, Hermann Building,
East Institute Drive, P.O. Box 12194,
Research Triangle, North Carolina
27709, made application by renewal to
the Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of the following basic
classes of controlled substances:
Drug
Schedule
mstockstill on DSK4VPTVN1PROD with NOTICES
Marihuana (7360) .........................
Cocaine (9041) .............................
I
II
The Institute will manufacture
marihuana, and cocaine derivatives for
use by their customers in analytical kits,
reagents, and reference standards as
directed by the National Institute on
Drug Abuse.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a), and
determined that the registration of
Research Triangle Institute to
manufacture the listed basic classes of
controlled substances is consistent with
the public interest at this time. DEA has
investigated Research Triangle Institute
to ensure that the company’s
VerDate Mar<15>2010
16:57 Sep 07, 2012
Jkt 226001
By Notice dated May 9, 2012, and
published in the Federal Register on
May 21, 2012, 77 FR 30026, Noramco,
Inc., 1440 Olympic Drive, Athens,
Georgia 30601, made application by
letter to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer of Gamma
Hydroxybutyric Acid (2010), a basic
class of controlled substance listed in
schedule I.
The company plans to manufacture
the listed controlled substance in bulk
for distribution to its customers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Noramco, Inc. to manufacture the listed
basic class of controlled substance is
consistent with the public interest at
this time. DEA has investigated
Noramco, Inc. to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823(a),
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic class of controlled substance
listed.
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
Dated: August 29, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2012–22129 Filed 9–7–12; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration;
Alltech Associates, Inc.
By Notice dated May 15, 2012 and
published in the Federal Register on
May 22, 2012, 77 FR 30327, Alltech
Associates, Inc., 2051 Waukegan Road,
Deerfield, Illinois 60015, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
the following basic classes of controlled
substances:
Drug
Methcathinone (1237) ..................
N-Ethylamphetamine (1475) ........
N,N-Dimethylamphetamine (1480)
4-Methylaminorex (cis isomer)
(1590).
Alpha-ethyltryptamine (7249) .......
Lysergic acid diethylamide (7315)
2,5-Dimethoxy-4-(n)propylthiophenethylamine
(7348).
Tetrahydrocannabinols (7370) .....
Mescaline (7381) ..........................
4-Bromo-2,5-dimethoxy-amphetamine (7391).
4-Bromo-2,5dimethoxyphenethylamine
(7392).
4-Methyl-2,5-dimethoxy-amphetamine (7395).
2,5-Dimethoxyamphetamine
(7396).
2,5-Dimethoxy-4ethylamphetamine (7399).
3,4-Methylenedioxyamphetamine
(7400).
N-Hydroxy-3,4methylenedioxyamphetamine
(7402).
3,4-Methylenedioxy-Nethylamphetamine (7404).
3,4Methylenedioxymethamphetamine (7405).
4-Methoxyamphetamine (7411) ...
Alpha-methyltryptamine (7432) ....
Bufotenine (7433) .........................
Diethyltryptamine (7434) ..............
Dimethyltryptamine (7435) ...........
Psilocybin (7437) ..........................
Psilocyn (7438) .............................
5-Methoxy-N,Ndiisopropyltryptamine (7439).
N-Ethyl-1-phenylcyclohexylamine
(7455).
E:\FR\FM\10SEN1.SGM
10SEN1
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
]]>Agencies
[Federal Register Volume 77, Number 175 (Monday, September 10, 2012)]
[Notices]
[Pages 55503-55504]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-22157]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Registration;
Cambrex Charles City, Inc.
By Notice dated June 18, 2012, and published in the Federal
Register on June 26, 2012, 77 FR 38085, Cambrex Charles City, Inc.,
1205 11th Street, Charles City, Iowa 50616-3466, made application by
renewal to the Drug Enforcement Administration (DEA) to be registered
as an importer of the following basic classes of controlled substances:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
4-Anilino-N-phenethyl-4-piperidine (8333).. II
Phenylacetone (8501)....................... II
Opium, raw (9600).......................... II
Poppy Straw Concentrate (9670)............. II
------------------------------------------------------------------------
The company plans to import the listed controlled substances for
internal use, and to manufacture bulk intermediates for sale to its
customers. No comments or objections have been received. Comments and
requests for hearings on applications to import narcotic raw material
are not appropriate. 72 FR 3417 (2007).
DEA has considered the factors in 21 U.S.C. 823(a) and 952(a), and
determined that the registration of Cambrex Charles City, Inc. to
import the
[[Page 55504]]
basic classes of controlled substances is consistent with the public
interest, and with United States obligations under international
treaties, conventions, or protocols in effect on May 1, 1971. DEA has
investigated Cambrex Charles City, Inc. to ensure that the company's
registration is consistent with the public interest. The investigation
has included inspection and testing of the company's physical security
systems, verification of the company's compliance with state and local
laws, and a review of the company's background and history.
Therefore, pursuant to 21 U.S.C .952(a) and 958(a), and in
accordance with 21 CFR 1301.34, the above named company is granted
registration as an importer of the basic classes of controlled
substances listed.
Dated: August 29, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2012-22157 Filed 9-7-12; 8:45 am]
BILLING CODE 4410-09-P
